Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands.
Autorzy:
de Boer PT; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. van de Kassteele J; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. Vos ERA; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. van Asten L; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. Dongelmans DA; Department of Intensive Care Medicine Amsterdam UMC (location AMC) Amsterdam The Netherlands.; Amsterdam Public Health Research Institute Amsterdam The Netherlands. vanGageldonk-LafeberAB; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. den Hartog G; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.; Laboratory of Medical Immunology Radboudumc Nijmegen The Netherlands. Hofhuis A; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. van der Klis F; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. de Lange DW; Intensive Care, University Medical Center Utrecht University of Utrecht Utrecht The Netherlands. Stoeldraijer L; Statistics Netherlands The Hague The Netherlands. de Melker HE; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. Geubbels E; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. van den Hof S; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. Wallinga J; Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.; Department of Biomedical Data Sciences Leiden University Medical Center Leiden The Netherlands.
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Aug 22; Vol. 17 (8), pp. e13174. Date of Electronic Publication: 2023 Aug 22 (Print Publication: 2023).
Inference of age-dependent case-fatality ratios for seasonal influenza virus subtypes A(H3N2) and A(H1N1)pdm09 and B lineages using data from the Netherlands.
Autorzy:
McDonald SA; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. Teirlinck AC; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. Hooiveld M; Nivel Utrecht The Netherlands. van Asten L; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. Meijer A; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. de Lange M; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. vanGageldonk-LafeberAB; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. Wallinga J; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.; Department of Biomedical Data Sciences Leiden University Medical Center Leiden The Netherlands.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Jun 19; Vol. 17 (6), pp. e13146. Date of Electronic Publication: 2023 Jun 19 (Print Publication: 2023).
Costs of a clinical pathway with point-of-care testing during influenza epidemic in a Dutch hospital.
Autorzy:
Marbus SD; National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Lutgens SPM; Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. vanGageldonk-LafeberAB; National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Hazenberg EHLCM; Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. Hermans MHA; Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. Suijkerbuijk AWM; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands.
Determinants of Fatal Outcome in Patients Admitted to Intensive Care Units With Influenza, European Union 2009-2017.
Autorzy:
Adlhoch C; Surveillance and Response Support, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden. Gomes Dias J; Surveillance and Response Support, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden. Bonmarin I; Bruno Hubert, Santé Public France, Saint-Maurice Cedex, France. Hubert B; Bruno Hubert, Santé Public France, Saint-Maurice Cedex, France. Larrauri A; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública, Institute of Health Carlos III (ISCIII), Madrid, Spain. Oliva Domínguez JA; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública, Institute of Health Carlos III (ISCIII), Madrid, Spain. Delgado-Sanz C; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública, Institute of Health Carlos III (ISCIII), Madrid, Spain. Brytting M; The Public Health Agency of Sweden, Solna, Sweden. Carnahan A; The Public Health Agency of Sweden, Solna, Sweden. Popovici O; National Institute of Public Health, Romania National Centre for Communicable Diseases Surveillance and Control, Bucuresti, Romania. Lupulescu E; National Institute of Public Health, Romania National Centre for Communicable Diseases Surveillance and Control, Bucuresti, Romania. O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland. Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland. VanGageldonk-LafeberAB; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Kynčl J; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic. Slezák P; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic. Guiomar R; Instituto Nacional de Saúde Doutor Ricardo Jorge (National Institute of Health Dr. Ricardo Jorge), Lisboa, Portugal. Orta Gomes CM; Department of Public Health of Regional Health Administration of Lisbon and Tagus Valley, Lisboa, Portugal. Popow-Kraupp T; Medical University of Vienna, Center for Virology, Vienna, Austria. Mikas J; Public Health Authority of the Slovak Republic, Bratislava, Slovakia. Staroňová E; Public Health Authority of the Slovak Republic, Bratislava, Slovakia. Melillo JM; Infectious Disease Prevention and Control Unit, Health Regulation, Malta. Melillo T; Infectious Disease Prevention and Control Unit, Health Regulation, Malta. Ikonen N; Department of Health Security, National Institute for Health and Welfare (THL), Helsinki, Finland. Lyytikäinen O; Department of Health Security, National Institute for Health and Welfare (THL), Helsinki, Finland. Snacken R; Surveillance and Response Support, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden. Penttinen P; Office of the Chief Scientist, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2019 Oct 29; Vol. 6 (11), pp. ofz462. Date of Electronic Publication: 2019 Oct 29 (Print Publication: 2019).
Remarkable spatial variation in the seroprevalence of Coxiella burnetii after a large Q fever epidemic.
Autorzy:
Pijnacker R; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, (RIVM), PO Box 1, 3720 BA, Bilthoven, the Netherlands. .; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden. . Reimerink J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, (RIVM), PO Box 1, 3720 BA, Bilthoven, the Netherlands. Smit LAM; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands. vanGageldonk-LafeberAB; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, (RIVM), PO Box 1, 3720 BA, Bilthoven, the Netherlands. Zock JP; Netherlands Institute for Health Services Research, (NIVEL), Utrecht, the Netherlands. Borlée F; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.; Netherlands Institute for Health Services Research, (NIVEL), Utrecht, the Netherlands. Yzermans J; Netherlands Institute for Health Services Research, (NIVEL), Utrecht, the Netherlands. Heederik DJJ; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands. Maassen CBM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, (RIVM), PO Box 1, 3720 BA, Bilthoven, the Netherlands. van der Hoek W; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, (RIVM), PO Box 1, 3720 BA, Bilthoven, the Netherlands.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2017 Nov 21; Vol. 17 (1), pp. 725. Date of Electronic Publication: 2017 Nov 21.
Livestock-associated risk factors for pneumonia in an area of intensive animal farming in the Netherlands.
Autorzy:
Freidl GS; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. Spruijt IT; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Borlée F; Institute for Risk Assessment Sciences (IRAS), Division of Environmental Epidemiology, Utrecht University, Utrecht, the Netherlands.; Netherlands Institute for Health Services Research (NIVEL), Utrecht, Netherlands. Smit LA; Institute for Risk Assessment Sciences (IRAS), Division of Environmental Epidemiology, Utrecht University, Utrecht, the Netherlands. vanGageldonk-LafeberAB; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Heederik DJ; Institute for Risk Assessment Sciences (IRAS), Division of Environmental Epidemiology, Utrecht University, Utrecht, the Netherlands. Yzermans J; Netherlands Institute for Health Services Research (NIVEL), Utrecht, Netherlands. van Dijk CE; Netherlands Institute for Health Services Research (NIVEL), Utrecht, Netherlands. Maassen CB; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. van der Hoek W; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Mar 31; Vol. 12 (3), pp. e0174796. Date of Electronic Publication: 2017 Mar 31 (Print Publication: 2017).
Hepatitis E virus seroprevalence among the general population in a livestock-dense area in the Netherlands: a cross-sectional population-based serological survey.
Autorzy:
vanGageldonk-LafeberAB; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. rianne.van.gageldonk@rivm.nl. van der Hoek W; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Borlée F; Institute for Risk Assessment Sciences, IRAS, Utrecht University, Utrecht, The Netherlands.; Netherlands Institute for Health Services Research (NIVEL), Utrecht, The Netherlands. Heederik DJ; Institute for Risk Assessment Sciences, IRAS, Utrecht University, Utrecht, The Netherlands. Mooi SH; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Maassen CB; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Yzermans CJ; Netherlands Institute for Health Services Research (NIVEL), Utrecht, The Netherlands. Rockx B; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Smit LA; Institute for Risk Assessment Sciences, IRAS, Utrecht University, Utrecht, The Netherlands. Reimerink JH; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2017 Jan 05; Vol. 17 (1), pp. 21. Date of Electronic Publication: 2017 Jan 05.
Characteristics of hospitalized acute Q fever patients during a large epidemic, The Netherlands.
Autorzy:
Wielders CC; Department of Medical Microbiology and Infection Control, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Wuister AM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Department of Internal Medicine, Bernhoven Hospital, Uden, the Netherlands. de Visser VL; Department of Pulmonary Diseases, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands. de Jager-Leclercq MG; Department of Internal Medicine, Bernhoven Hospital, Uden, the Netherlands. Groot CA; Department of Pulmonary Diseases, Bernhoven Hospital, Uden, the Netherlands. Dijkstra F; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. vanGageldonk-LafeberAB; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. van Leuken JP; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Institute for Risk Assessment Sciences, Faculty of Veterinary Sciences, Utrecht University, Utrecht, the Netherlands. Wever PC; Department of Medical Microbiology and Infection Control, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands. van der Hoek W; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Schneeberger PM; Department of Medical Microbiology and Infection Control, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Mar 10; Vol. 9 (3), pp. e91764. Date of Electronic Publication: 2014 Mar 10 (Print Publication: 2014).
The relative clinical impact of 2009 pandemic influenza A (H1N1) in the community compared to seasonal influenza in the Netherlands was most marked among 5-14 year olds.
Surveillance recommendations based on an exploratory analysis of respiratory syncytial virus reports derived from the European Influenza Surveillance System.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
